The effect of iliopsoas plane block on opioid consumption and pain after hip arthroscopy

Phase 1

• Conditions: Postoperative pain after hip arthroscopy; MedDRA version: 21.0Level: LLTClassification code 10080604Term: Hip arthroscopySystem Organ Class: 100000004848; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2020-005838-15-DK
• Lead Sponsor: Aarhus University Hospiotal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-15
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

•Set for elective primary hip arthroscopy by one single otrhopedic surgeon
•Planned generel anesthesia with Propofol og Remifentanil
•ASA I-III
•Patient = 18 years
•Informeret consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 45
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

• Inability to cooperate
• Unable to speak and/or understand Danish or other types of communication problems
• Allergy to local analgesics in the study (Marcain + adrenaline)
• Lack of tolerance of both Morphine and Oxycodone
• Chronic pain with daily opioid consumption (dosed > x 1Day)
• Chronic pain and treatment with gabapentin, pregabalin, tricyclic antidepressants, opioid antagonists or SNRI
• Treatment with antipsychotics
• Known abuse of alcohol, drugs or medicine
• Previous hip surgery on the planned site for this hip artroscopy
• Previous participation in this study
• Pregnancy

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: The purpose of the trial is to assess the analgesic effect of preoperatively placed active or placebo iliopsoas plane block for elective primary hip arthroscopy.<br>The primary objective of the study is to investigate morphine consumption;Secondary Objective: The secondary goal are to investyigate pain and morphine side effects. ;Primary end point(s): Cumulative opioid consumption by PCA pump (patient controlled analgesia) in the first 180 min in PACU after primary hip arthroscopy for patients with active or placebo iliopsoas plane blockade.;Timepoint(s) of evaluation of this end point: 180 min. after arrival to PACU